Ford CA, Koludrovic D, Centeno PP, Foth M, et al. Targeting the PREX2/RAC1/PI3Kbeta Signaling Axis Confers Sensitivity to Clinically Relevant Therapeutic Approaches in Melanoma. Cancer Res 2024 Dec 5. doi: 10.1158/0008-5472.CAN-23-2814.
PMID: 39636745